HK1090093A1 - Method of selecting patients suitable for wt1 vaccine - Google Patents
Method of selecting patients suitable for wt1 vaccineInfo
- Publication number
- HK1090093A1 HK1090093A1 HK06110635.4A HK06110635A HK1090093A1 HK 1090093 A1 HK1090093 A1 HK 1090093A1 HK 06110635 A HK06110635 A HK 06110635A HK 1090093 A1 HK1090093 A1 HK 1090093A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- vaccine
- selecting patients
- biological sample
- precursor cells
- highly responsive
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 239000012472 biological sample Substances 0.000 abstract 2
- 239000002243 precursor Substances 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000004043 responsiveness Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003184436 | 2003-06-27 | ||
| JP2004070497 | 2004-03-12 | ||
| PCT/JP2004/009378 WO2005001117A1 (fr) | 2003-06-27 | 2004-06-25 | Procede de selection d'un patient s'adaptant au vaccin anti-wt1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1090093A1 true HK1090093A1 (en) | 2006-12-15 |
Family
ID=33554467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK06110635.4A HK1090093A1 (en) | 2003-06-27 | 2006-09-22 | Method of selecting patients suitable for wt1 vaccine |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10500257B2 (fr) |
| EP (3) | EP2338509B1 (fr) |
| JP (1) | JP4566912B2 (fr) |
| KR (2) | KR101431312B1 (fr) |
| CN (1) | CN1842603B (fr) |
| AT (1) | ATE538809T1 (fr) |
| CA (2) | CA2893995A1 (fr) |
| ES (3) | ES2443582T3 (fr) |
| HK (1) | HK1090093A1 (fr) |
| WO (1) | WO2005001117A1 (fr) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1178956C (zh) * | 1998-07-31 | 2004-12-08 | 杉山治夫 | 基于癌抑制基因wt1的产物的癌抗原 |
| KR100863853B1 (ko) | 2001-03-22 | 2008-10-15 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | 더블유티1 개변 펩티드 |
| EP1550453B1 (fr) * | 2002-09-12 | 2015-05-27 | International Institute of Cancer Immunology, Inc. | Preparation de peptides antigenes du cancer |
| ES2443582T3 (es) | 2003-06-27 | 2014-02-19 | International Institute Of Cancer Immunology, Inc. | Método para diagnosticar el cáncer que comprende la medición de las células precursoras de CTL específicos de WT1 |
| CA2544214C (fr) | 2003-11-05 | 2018-08-28 | International Institute Of Cancer Immunology, Inc. | Peptide antigene se liant a hla-dr d'origine wt1 |
| WO2005095598A1 (fr) * | 2004-03-31 | 2005-10-13 | International Institute Of Cancer Immunology, Inc. | Peptide d'antigène du cancer issu de wt1 |
| WO2006081826A2 (fr) * | 2005-02-04 | 2006-08-10 | Survac Aps | Vaccin a base de peptide de survivine |
| CA2626238C (fr) | 2005-10-17 | 2015-10-06 | Sloan Kettering Institute For Cancer Research | Peptides de liaison wt1 hla de classe ii, compositions et methodes associees comprenant ces peptides |
| PL1961761T3 (pl) * | 2005-11-30 | 2011-04-29 | Int Inst Cancer Immunology Inc | Oligomeryczne amidoaminy lub amidokwaty do kompozycji do obróbki tkanin lub włosów |
| US9265816B2 (en) | 2006-04-10 | 2016-02-23 | Sloan Kettering Institute For Cancer Research | Immunogenic WT-1 peptides and methods of use thereof |
| EP2392672A1 (fr) * | 2006-06-02 | 2011-12-07 | GlaxoSmithKline Biologicals S.A. | Procédé d'identification si un patient est réactif ou non à l'immunothérapie basé sur l'expression différentielle du gène CD52 |
| KR101598228B1 (ko) | 2007-02-27 | 2016-02-26 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | 헬퍼 ｔ 세포의 활성화 방법 및 그를 위한 조성물 |
| JP5808079B2 (ja) | 2007-03-05 | 2015-11-10 | 株式会社癌免疫研究所 | 癌抗原特異的ｔ細胞のレセプター遺伝子およびそれによりコードされるペプチドならびにそれらの使用 |
| RU2010127298A (ru) | 2007-12-05 | 2012-01-10 | Интернешнл Инститьют Оф Кэнсер Иммунолоджи, Инк. (Jp) | Вакцинная композиция против злокачественной опухоли |
| MY170306A (en) | 2010-10-05 | 2019-07-17 | Int Inst Cancer Immunology Inc | Method for activating helper t cell |
| JP6066909B2 (ja) | 2011-06-28 | 2017-01-25 | 株式会社癌免疫研究所 | ペプチド癌抗原特異的ｔ細胞のレセプター遺伝子 |
| EP2561759A1 (fr) | 2011-08-26 | 2013-02-27 | Bayer Cropscience AG | 2-amidobenzimidazoles fluoroalkyl substitués et leur effet sur la croissance des plantes |
| JP6100265B2 (ja) | 2011-09-16 | 2017-03-22 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ | 植物収量を向上させるためのフェニルピラゾリン−３−カルボン酸化合物の使用 |
| WO2013037956A1 (fr) | 2011-09-16 | 2013-03-21 | Bayer Intellectual Property Gmbh | Utilisation de 5-phényl- ou de 5-benzyl-2 isoxazoline-3 carboxylates pour améliorer le rendement de végétaux |
| EA029208B1 (ru) | 2011-09-16 | 2018-02-28 | Байер Интеллектуэль Проперти Гмбх | Способ повышения урожайности пригодных для заготовки частей растений полезных растений или сельскохозяйственных культур и композиция для повышения урожайности растений |
| AU2013207669C1 (en) | 2012-01-13 | 2018-05-31 | Memorial Sloan Kettering Cancer Center | Immunogenic WT-1 peptides and methods of use thereof |
| CN105007930B (zh) | 2012-10-23 | 2018-08-17 | 优比维克有限责任公司 | 用于治疗疾病的同种异体自噬体富集组合物 |
| ES2805337T3 (es) | 2012-12-17 | 2021-02-11 | Otsuka Pharma Co Ltd | Método para activar células T auxiliares |
| JP6486278B2 (ja) * | 2013-01-15 | 2019-03-20 | メモリアル スローン ケタリング キャンサー センター | 免疫原性ｗｔ−１ペプチドおよびその使用法 |
| US10815273B2 (en) | 2013-01-15 | 2020-10-27 | Memorial Sloan Kettering Cancer Center | Immunogenic WT-1 peptides and methods of use thereof |
| CA2903624C (fr) | 2013-03-05 | 2023-03-07 | Bayer Cropscience Aktiengesellschaft | Utilisation d'acylsulfonamides pour ameliorer le rendement de plantes |
| DK2964027T3 (da) | 2013-03-05 | 2019-07-15 | Bayer Cropscience Ag | Anvendelse af kombinationer, der omfatter cloquintocet-mexyl, til forbedring af planteudbytte |
| US10001491B2 (en) * | 2013-03-28 | 2018-06-19 | Centre Hospitalier Universitaire De Montpellier | Method for determining radiosensitivity |
| US10408840B2 (en) | 2013-05-13 | 2019-09-10 | International Institute Of Cancer Immunology, Inc. | Method for predicting clinical effect of immunotherapy |
| SI3377516T1 (sl) | 2015-11-20 | 2023-01-31 | Memorial Sloan Kettering Cancer Center, Office of Industrial Affairs | Sestavek za zdravljenje raka |
| EP3318135A1 (fr) | 2016-11-03 | 2018-05-09 | Perfetti Van Melle S.p.A. | Matériau de bonbon effervescent, son procédé de préparation et produits fabriqués à partir de celui-ci |
| WO2021230247A1 (fr) * | 2020-05-12 | 2021-11-18 | 大日本住友製薬株式会社 | Composition pharmaceutique pour le traitement du cancer |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923799A (en) | 1984-02-06 | 1990-05-08 | The Ontario Cancer Institute | T cell specific cDNA clone |
| US6582908B2 (en) | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| WO1993004695A1 (fr) | 1991-08-28 | 1993-03-18 | The Wistar Institute | Therapie de la polyarthrite rhumatoide basee sur le recepteur de lymphocytes t |
| US5364787A (en) | 1992-03-23 | 1994-11-15 | Idaho Research Foundation | Genes and enzymes involved in the microbial degradation of pentachlorophenol |
| WO1997039354A1 (fr) * | 1996-04-16 | 1997-10-23 | Kishimoto, Tadamitsu | Procede de detection de cellules solides cancereuses et d'heterotypie histologique et procede d'examen du tissu dans le but d'effectuer une transplantation de moelle osseuse et une transplantation de cellules souches du sang peripherique |
| GB9710820D0 (en) | 1997-05-27 | 1997-07-23 | Univ Dundee | Immunological method |
| US6013444A (en) | 1997-09-18 | 2000-01-11 | Oligotrail, Llc | DNA bracketing locus compatible standards for electrophoresis |
| WO1999027957A1 (fr) | 1997-12-03 | 1999-06-10 | The Immune Response Corporation | Vaccination et procede de lutte contre la sclerose en plaques au moyen de peptides tcr vbeta specifiques |
| IL139344A0 (en) | 1998-05-19 | 2001-11-25 | Avidex Ltd | Soluble t cell receptor |
| CN1178956C (zh) | 1998-07-31 | 2004-12-08 | 杉山治夫 | 基于癌抑制基因wt1的产物的癌抗原 |
| JP4243792B2 (ja) | 1998-09-30 | 2009-03-25 | コリクサ コーポレイション | Ｗｔ１特異的免疫療法のための組成物および方法 |
| US20030072767A1 (en) * | 1998-09-30 | 2003-04-17 | Alexander Gaiger | Compositions and methods for WT1 specific immunotherapy |
| US20030235557A1 (en) | 1998-09-30 | 2003-12-25 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| GB9823897D0 (en) | 1998-11-02 | 1998-12-30 | Imp College Innovations Ltd | Immunotherapeutic methods and molecules |
| NZ513630A (en) | 1999-02-23 | 2001-09-28 | Baylor College Medicine | T cell receptor Vβ-Dβ-Jβ sequence and methods for its detection |
| WO2001094944A2 (fr) | 2000-06-02 | 2001-12-13 | Memorial Sloan-Kettering Cancer Center | Cellules presentatrices d'antigene artificiel et leurs methodes d'utilisation |
| US20050050580A1 (en) | 2000-12-13 | 2005-03-03 | Masashi Gotoh | Transgenic animal expressing hla-a24 and utilization thereof |
| KR100863853B1 (ko) | 2001-03-22 | 2008-10-15 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | 더블유티1 개변 펩티드 |
| CN1320923C (zh) | 2001-06-29 | 2007-06-13 | 中外制药株式会社 | 含有基于癌抑制基因wt1的产物的癌抗原和阳离子脂质体的癌疫苗 |
| US20060035291A1 (en) | 2001-09-18 | 2006-02-16 | Kyogo Itoh | Method of detecting cellular immunity and application thereof to drugs |
| WO2003028758A1 (fr) | 2001-09-28 | 2003-04-10 | Haruo Sugiyama | Nouvelle methode d'induction de lymphocytes t specifiques d'un antigene |
| JP5230891B2 (ja) | 2001-09-28 | 2013-07-10 | 株式会社癌免疫研究所 | 抗原特異的ｔ細胞の新規な誘導方法 |
| WO2003059155A2 (fr) | 2002-01-09 | 2003-07-24 | Maxx Genetech Co. Ltd | Procede de detection de la proliferation de lymphocytes t pour le diagnostique de maladies a l'aide d'un ensemble de genes |
| AU2003242305A1 (en) | 2002-06-12 | 2003-12-31 | Chugai Seiyaku Kabushiki Kaisha | Hla-a24-restricted cancer antigen peptide |
| EP1550453B1 (fr) * | 2002-09-12 | 2015-05-27 | International Institute of Cancer Immunology, Inc. | Preparation de peptides antigenes du cancer |
| WO2004063706A2 (fr) | 2003-01-08 | 2004-07-29 | Maxx Genetech Co., Ltd. | Procede permettant de detecter la surexpression des genes du recepteur des lymphocytes t par pcr en temps reel |
| ES2443582T3 (es) | 2003-06-27 | 2014-02-19 | International Institute Of Cancer Immunology, Inc. | Método para diagnosticar el cáncer que comprende la medición de las células precursoras de CTL específicos de WT1 |
| CA2544214C (fr) | 2003-11-05 | 2018-08-28 | International Institute Of Cancer Immunology, Inc. | Peptide antigene se liant a hla-dr d'origine wt1 |
| WO2005053603A2 (fr) | 2003-12-08 | 2005-06-16 | Yeda Research And Development Co. Ltd. | Typage d'une region variable du recepteur de l'antigene |
| US7576183B2 (en) | 2003-12-24 | 2009-08-18 | Los Alamos National Security, Llc | Structure-based receptor MIMICS targeted against bacterial superantigen toxins |
| WO2005095598A1 (fr) | 2004-03-31 | 2005-10-13 | International Institute Of Cancer Immunology, Inc. | Peptide d'antigène du cancer issu de wt1 |
| GB0411771D0 (en) | 2004-05-26 | 2004-06-30 | Avidex Ltd | Nucleoproteins displaying native T cell receptor libraries |
| GB0427585D0 (en) | 2004-12-16 | 2005-01-19 | Avidex Ltd | Assay |
| WO2008026927A2 (fr) | 2006-08-30 | 2008-03-06 | Academisch Medisch Centrum | Procédé d'affichage des répertoires des récepteurs des lymphocytes t et b |
| JP5808079B2 (ja) | 2007-03-05 | 2015-11-10 | 株式会社癌免疫研究所 | 癌抗原特異的ｔ細胞のレセプター遺伝子およびそれによりコードされるペプチドならびにそれらの使用 |
| JP2009278927A (ja) | 2008-05-23 | 2009-12-03 | Tohoku Univ | Ｔ細胞受容体を模倣する抗体断片及びその製造方法 |
| JP6066909B2 (ja) | 2011-06-28 | 2017-01-25 | 株式会社癌免疫研究所 | ペプチド癌抗原特異的ｔ細胞のレセプター遺伝子 |
-
2004
- 2004-06-25 ES ES11154325.2T patent/ES2443582T3/es active Active
- 2004-06-25 AT AT04746847T patent/ATE538809T1/de active
- 2004-06-25 KR KR1020117006813A patent/KR101431312B1/ko active IP Right Grant
- 2004-06-25 KR KR1020057024941A patent/KR101292971B1/ko active IP Right Grant
- 2004-06-25 EP EP11154327.8A patent/EP2338509B1/fr not_active Not-in-force
- 2004-06-25 EP EP04746847A patent/EP1640458B1/fr not_active Not-in-force
- 2004-06-25 WO PCT/JP2004/009378 patent/WO2005001117A1/fr active Application Filing
- 2004-06-25 CA CA2893995A patent/CA2893995A1/fr not_active Abandoned
- 2004-06-25 CN CN2004800245592A patent/CN1842603B/zh not_active Expired - Fee Related
- 2004-06-25 US US10/562,486 patent/US10500257B2/en not_active Expired - Fee Related
- 2004-06-25 ES ES11154327.8T patent/ES2478446T3/es active Active
- 2004-06-25 EP EP11154325.2A patent/EP2343083B1/fr not_active Not-in-force
- 2004-06-25 JP JP2005511121A patent/JP4566912B2/ja not_active Expired - Fee Related
- 2004-06-25 ES ES04746847T patent/ES2378156T3/es active Active
- 2004-06-25 CA CA2530184A patent/CA2530184C/fr not_active Expired - Fee Related
-
2006
- 2006-09-22 HK HK06110635.4A patent/HK1090093A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4566912B2 (ja) | 2010-10-20 |
| EP1640458A1 (fr) | 2006-03-29 |
| US20070128207A1 (en) | 2007-06-07 |
| KR20060069363A (ko) | 2006-06-21 |
| ES2443582T3 (es) | 2014-02-19 |
| EP2338509A3 (fr) | 2011-11-30 |
| EP2338509A2 (fr) | 2011-06-29 |
| KR101431312B1 (ko) | 2014-08-20 |
| EP2338509B1 (fr) | 2014-06-18 |
| ES2478446T3 (es) | 2014-07-22 |
| EP2343083A3 (fr) | 2011-08-03 |
| EP2343083B1 (fr) | 2014-01-15 |
| CA2530184C (fr) | 2015-10-06 |
| US10500257B2 (en) | 2019-12-10 |
| CA2530184A1 (fr) | 2005-01-06 |
| CN1842603A (zh) | 2006-10-04 |
| KR101292971B1 (ko) | 2013-08-12 |
| WO2005001117A1 (fr) | 2005-01-06 |
| ATE538809T1 (de) | 2012-01-15 |
| CA2893995A1 (fr) | 2005-01-06 |
| CN1842603B (zh) | 2013-09-11 |
| ES2378156T3 (es) | 2012-04-09 |
| EP2343083A2 (fr) | 2011-07-13 |
| EP1640458A4 (fr) | 2008-05-21 |
| JPWO2005001117A1 (ja) | 2006-08-10 |
| EP1640458B1 (fr) | 2011-12-28 |
| KR20110049877A (ko) | 2011-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1090093A1 (en) | Method of selecting patients suitable for wt1 vaccine | |
| RU2007141067A (ru) | Терапия с помощью антител к egfr, основанная на повышенном числе копий гена egfr в опухолевых тканях | |
| TW200626899A (en) | Frizzled proteins and detection and treatment of cancer | |
| WO2014036495A3 (fr) | Dosages diagnostiques et nécessaires de détection du récepteur-1 aux folates | |
| WO2004092353A3 (fr) | Complexes de recepteurs de surface utilises comme biomarqueurs | |
| DE60129151D1 (de) | Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) | |
| WO2003014395A1 (fr) | Methode d'examen de l'asthme bronchique | |
| WO2003016464A3 (fr) | Sequences d'oligosaccharides specifiques pour le cancer et leur utilisation | |
| Chonanant et al. | Characterisation of chondrogenic differentiation of human mesenchymal stem cells using synchrotron FTIR microspectroscopy | |
| WO2005040421A3 (fr) | Marqueurs de pronostic et de diagnostic des troubles de proliferation cellulaire dans les tissus mammaires | |
| EA201590686A1 (ru) | Тест на митохондриальную токсичность | |
| DE50300981D1 (de) | Verfahren und Vorrichtung zur Messung von Blutgasparametern | |
| WO2006023563A3 (fr) | Dispositif d'imagerie diagnostique pour analyser des cellules rares circulantes | |
| WO2012044696A3 (fr) | Prédiction de résultats cliniques dans des malignités hématologiques au moyen d'une signature de l'expression d'auto-renouvellement | |
| CN109313195B (zh) | 用于提供胆道癌诊断信息的方法和用于诊断胆道癌的装置 | |
| Yao et al. | The use of FTIR-ATR spectrometry for evaluation of surgical resection margin in colorectal cancer: A pilot study of 56 samples | |
| ATE514951T1 (de) | Verfahren zur prüfung eines mehrkanaligen elements zur blutanalyse | |
| WO2004104591A3 (fr) | Ameliorations apportees a une therapie induite par des lymphocytes t gamma-delta | |
| CN207488145U (zh) | 一种血液肿瘤用检测装置 | |
| BRPI0315735B8 (pt) | método para o ensaio de ngf a diagnose in vitro de câncer de mama e uso terapêutico | |
| HUP0203408A2 (hu) | Eljárás hiperlipémia elleni preventív vagy terápiás hatóanyag tesztelésére | |
| WO2012032511A3 (fr) | Kit de surveillance, dépistage et stadification de la maladie du greffon contre l'hôte | |
| EP1988164A4 (fr) | Procédé destiné à tester la sensibilité d'un cancer solide contre un inhibiteur de tyrosine kinase et nécessaire de test correspondant | |
| WO2005040806A3 (fr) | Utilisation de la protéine asc comme marqueur du cancer du sein | |
| Cummins et al. | Raman spectroscopy of fingernails: A novel tool for evaluation of bone quality? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20200625 |